Policy & Medicine - Legal, Regulatory, and Compliance Issues

The relationship between health professionals and the pharmaceutical industry has become a source of controversy and a major topic…

Last year, the Food and Drug Administration (FDA) launched “The Bad Ad Program,” which is designed to educate health care…

 A recent post on the blog, Clinical Researchers, provided a wealth of information for health care providers and stakeholders…

A recent commentary from Nature Medicine explained how recent “concerns about conflicts of interest have driven a wedge between…

Cancer is arguably the most feared disease, or set of diseases, facing humanity. The symptoms of cancer can be severe and…

Last year, an opinion from the United States Court of Appeals for the First Circuit concluded that a Vermont law, which banned…

A little over ten years ago, while on vacation, I brought my son to a walk in clinic for an earache.  The physician working that…

Imagine a world where every time someone accessed a patients record from the billing clerk to physicians, nurses and pharmacists,…

Earlier this week, the American Medical Association House of Delegates (AMA HOD) passed the Council on Judicial and Ethical…

A recent article from the Sun Journal explained that Maine could soon shed a 2003 law designed to protect consumers from high drug…